Increasing Human Papillomavirus Vaccine Coverage Among Men Who Have Sex With Men—National HIV Behavioral Surveillance, United States, 2014

Abstract

Background Human papillomavirus (HPV) can cause oropharyngeal and anogenital cancers among men who have sex with men (MSM). In 2011, the Advisory Committee on Immunization Practices (ACIP) extended HPV vaccine recommendations to males through age 21 and MSM through age 26. Because of this distinction, vaccination for some MSM might rely on sexual behavior disclosure to health care providers. Receipt of ≥1 HPV vaccination among MSM aged 18–26 in National HIV Behavioral Surveillance (NHBS) was 4.9% in 2011. We evaluated HPV vaccine coverage and associated factors among MSM in 2014. Setting Twenty US metropolitan statistical areas in 2014. Methods Coverage was calculated as percentage of MSM self-reporting ≥1 HPV vaccination. Adjusted prevalence ratios were calculated from Poisson regression models to estimate associations of demographic and behavioral characteristics with HPV vaccination. Results Among 2892 MSM aged 18–26 years, HPV vaccine coverage was 17.2%. Overall, 2326 (80.4%) reported a health care visit within 12 months, and 2095 (72.4%) disclosed MSM attraction or behavior to a health care provider. Factors associated with vaccination included self-reported HIV infection; having a health care visit within 12 months, health insurance, or a usual place of care; and disclosing MSM attraction or behavior to a health care provider. Conclusions Since the 2011 recommendation for vaccination of males, HPV vaccine coverage among MSM increased, but remains low. Most MSM reported a recent health care visit and disclosed sexual behavior, indicating opportunities for vaccination. Potential strategies for increasing MSM coverage include improving access to recommended care, and offering education for providers and patients.

Examining Facilitators of HPV Vaccination Uptake in Men Who Have Sex with Men: A Cross-Sectional Survey Design

“…Socio-demographic variables implicated in previous research, such as ethnicity (e.g., [10]), education (e.g., [12]), and number of sexual partners (e.g., [11]) were not significantly associated with uptake in the present research. Age was also not a significant correlate of uptake, which may indicate that results from research concerning young MSM may be applicable to older men as well.…”

Human papillomavirus vaccine uptake among young gay and bisexual men who have sex with men with a time-limited targeted vaccination programme through sexual health clinics in Melbourne in 2017

“…With the launch of a targeted HPV vaccination programme for MSM, the HPV vaccine uptake rate is at a level similar if not higher than what has been found in other studies. Two studies have shown that the HPV vaccine uptake rate was 21%17 and 17%29 among MSM aged 18–26 years in the USA. This highlights the fact that a targeted MSM programme is not sufficient to reach the critical vaccination threshold for MSM (at least 70%) 10 27.…”

A Qualitative Analysis of Young Sexual Minority Men's Perspectives on Human Papillomavirus Vaccination

“…[7][8][9] Nevertheless, HPV vaccine uptake among young MSM is less than optimal, with fewer than 40% initiating the series (i.e., receiving ‡1 dose of the 3-dose series). [10][11][12][13][14] Although researchers have begun to identify promising strategies for promoting HPV vaccination among young MSM, [15][16][17] few evidence-based interventions are currently available.…”